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Background: Uterine fibroids occur singly or as multiple benign tumors originating 
in the myometrium. Because they vary in size and location, the approach and tech-
nique for their identification and surgical management vary. Reference images, such as 
ultrasound images, magnetic resonance images, and sonohystograms, do not provide 
real-time intraoperative findings.
Methods: Electromagnetic image guidance, as incorporated in the Acessa Guid-
ance System, has been cleared by the FDA to facilitate targeting and ablation of 
uterine fibroids during laparoscopic surgery. This is the first feasibility study to verify 
the features and usefulness of the guidance system in targeting symptomatic uterine 
fibroids—particularly hard-to-reach intramural fibroids and those abutting the endo-
metrium. One gynecologic surgeon, who had extensive prior experience in laparo-
scopic ultrasound-guided identification of fibroids, treated five women with sympto-
matic uterine fibroids using the Acessa Guidance System. The surgeon evaluated the 
system and its features in terms of responses to prescribed statements; the responses 
were analyzed prospectively.
Results: The surgeon strongly agreed (96 %) or agreed (4 %) with statements describ-
ing the helpfulness of the transducer and handpiece’s dynamic animation in targeting 
each fibroid, reaching the fibroid quickly, visualizing the positions of the transducer and 
handpiece within the pelvic cavity, and providing the surgeon with confidence when 
targeting the fibroid even during “out-of-plane” positioning of the handpiece.
Conclusions: The surgeon’s positive user experience was evident in the guidance 
system’s facilitation of accurate handpiece tip placement during targeting and ablation 
of uterine fibroids. Continued study of electromagnetic image guidance in the laparo-
scopic identification and treatment of fibroids is warranted.
ClinicalTrials.gov Identifier: NCT01842789.
Keywords: Fibroids, Myomas, Ablation, Electromagnetic image guidance, Acessa
Open Access
© 2015 Galen. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://
creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided 
you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate 
if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/
zero/1.0/) applies to the data made available in this article, unless otherwise stated.
RESEARCH
Galen  BioMed Eng OnLine  (2015) 14:90 
DOI 10.1186/s12938-015-0086-5
*Correspondence:   
drgalen@drgalen.com 
2 13 Homestead Court, 
Danville, CA 94506, USA
Full list of author information 
is available at the end of the 
article
Page 2 of 6Galen  BioMed Eng OnLine  (2015) 14:90 
Background
Uterine fibroids are the most common benign gynecologic tumors, occurring in 70–80 % 
of women by the time they reach 50 years of age [1]. Their negative impact on family and 
sexual relationships, ability to perform at work, and enjoyment of day-to-day activities 
has been well documented in the literature [2–4]. Because uterine fibroids can occur sin-
gly or as multiple tumors and vary in size and location, the approach and technique for 
their identification and surgical management also varies.
Gynecologic surgeons traditionally have identified benign fibroid tissue using refer-
ence pre-operative transvaginal ultrasound and/or sonohysterography scans, contrast-
enhanced magnetic resonance images (cMRI), diagnostic hysteroscopy images, or tactile 
and/or visual identification at the time of surgery. Depending on the method, these 
approaches differ in terms of convenience, sensitivity, and range of associated direct 
costs from negligible (tactile identification) to costly (cMRI). In addition, reference 
images are static and do not provide real-time, intraoperative findings. Lack of real-time 
imaging is especially problematic for the surgeon if the patient has symptomatic intra-
mural fibroids or intramural fibroids abutting—but not distorting—the endometrium 
(IMAEs).
In late 2012, the FDA cleared the Acessa™ System (Halt Medical, Inc., Brentwood, 
CA, USA) for the treatment of uterine fibroids, including hard-to-reach intramurals. 
The System enables the identification and targeting of uterine fibroids via laparoscopy 
and laparoscopic ultrasound (LUS). Under standard laparoscopy, the surgeon uses a LUS 
transducer to guide the radiofrequency ablation (RFA) handpiece to the edge of the tar-
get fibroid. LUS, which evidences significant sensitivity, is used to guide in two-dimen-
sional space the insertion of the handpiece tip into the fibroid, which is subsequently 
ablated from the tip or from the deployed electrode array using generator settings that 
are based on the desired ablation zone [5–8].
In an effort to further facilitate targeting and ablation of symptomatic fibroids, par-
ticularly intramurals and IMAEs, Halt Medical recently developed (in partnership with 
InnerOptic Technology, Hillsborough, NC, USA) an electromagnetic image guidance 
system. The same electromagnetic image guidance system was previously studied and 
described by hepatobiliary surgeons, who attempted to target a strategically placed 
analog tumor in an agar block [9]. These surgeons tested their ability, time, and mental 
workload when targeting the analog tumor under different controlled conditions. The 
guidance system significantly reduced the number of required needle withdrawals and 
repositionings, and—once the surgeons achieved proficiency—their mental workload 
(as measured by the National Aeronautics and Space Administration Task Load Index) 
decreased significantly [9, 10]. This same system was applied to gynecologic use for tar-
geting uterine fibroids and was cleared by the FDA to enhance the ultrasonic image of 
the Acessa handpiece and predict its future path on a computer monitor screen.
This feasibility study is an analysis of one gynecologic surgeon’s experience with the 
Acessa Guidance System when used to target, access and ablate symptomatic subserosal, 
intramural, IMAE, and submucosal fibroids.
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Methods
This ongoing study is a post-market prospective evaluation of the Acessa System with 
targeting animation guidance (TAG) [ClinicalTrials.gov Identifier: NCT01842789] 
(Figs. 1, 2). Female premenopausal subjects ≥18 years of age and with symptomatic uter-
ine fibroids diagnosed on transvaginal ultrasound were recruited from one private gyne-
cology office located in the San Francisco Bay Area.
The guidance system is an electromagnetic positioning system designed to guide the 
Acessa handpiece to the target fibroid using an overlay of the US image. A very small 
wire coil (sensor) is incorporated both in the tip of the Acessa handpiece and at the dis-
tal end of a sheath placed over the LUS transducer. The coil in the handpiece tip meas-
ures 0.3 mm in diameter and 11.0 mm in length; the coil at the distal end of the LUS 
sheath measures 1.8 × 9.0 mm. Each sensor has its own local coordinate system, which 
is defined by an origin and three axes and is electrically connected to the system control-
ler. A flat field generator, placed underneath the patient’s pelvic area, generates an elec-
tromagnetic field. When the sensors are placed over the field generator, the magnetic 
field produced by the field generator causes the sensor coils to produce a small electri-
cal signal. The software uses the characteristics of the induced voltage from each sensor 
to create virtual representations of the LUS transducer and the handpiece in relation to 
their spatial relationship. These avatars are displayed on an external monitor and show 
the physician the future path of the handpiece in relation to the displayed LUS image of 
the target fibroid.
Fig. 1 Surgeon’s view of real-time operative screens (from left-to-right): laparoscopic view of radiofrequency 
ablation handpiece inserted into a large intramural fibroid, Acessa Guidance screens, and Acessa System 
screen prior to deployment of electrode array
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After the use of the guidance system in each patient, the surgeon filled out a pre-
scribed form to indicate his degree of agreement with statements regarding the features 
of the guidance system. His responses were collected prospectively and were analyzed 
using descriptive statistics and general trending analysis to summarize his user prefer-
ence testing responses.
The local Institutional Review Board approved the study, and all participants signed 
informed consent.
Results and discussion
Five female subjects (4 Caucasians and 1 African American; mean age, 42.3 ± 9.2 years 
of age), each of whom had 2–7 symptomatic subserosal, intramural, IMAE, and/or sub-
mucosal fibroids, were treated between July 23, 2013 and November 19, 2013 by one 
gynecologic surgeon. The diameters of the ablated fibroids ranged from 1.0 to 6.7 cm. 
The surgeon was highly experienced in LUS-guided targeting and ablation of uterine 
fibroids, having performed LUS-guided ablations on more than 300 fibroids prior to the 
study.
Despite this surgeon’s extensive experience with the standard Acessa procedure and 
approach (i.e., without electromagnetic image guidance), he strongly agreed (96 %) or 
agreed (4  %) with statements describing the helpfulness of the transducer and hand-
piece’s dynamic animation in targeting each fibroid, reaching the fibroid quickly, visu-
alizing the positions of the transducer and handpiece within the pelvic cavity, and 
providing the surgeon with confidence when targeting the fibroid even during “out-of-
plane” positioning of the handpiece (Table 1).
Electromagnetic image tracking systems were initially developed in the 1990s for vir-
tual reality and military applications [11, 12]. These systems are now widely used in the 
operating room in neurosurgery and otolaryngology and in vascular applications [13, 
Fig. 2 Acessa Guidance screens. (Left) Laparoscopic ultrasound view of Acessa handpiece tip entering fibroid 
from left to right within the two (purple) virtual tracking lines of the target zone; (right) computer-generated 
view of the relationship of the ultrasound beam and trajectory of the handpiece tip into uterus and fibroid
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14]. The Acessa Guidance System is the first FDA-cleared electromagnetic tracking sys-
tem developed for gynecologic surgery, and this is the first study to verify the system’s 
features and usefulness. The system does not require line of site, so the sensor coils 
can be imbedded near the tip of the instrument for sub-millimeter tracking accuracy. 
Tracking is correlated to intraoperative ultrasound and does not require registration of 
the patient to a previously obtained computerized tomography or magnetic resonance 
image.
Its significant application is in the targeting of those fibroids not readily visualized 
on laparoscopy (such as intramural fibroids) prior to ablation. Intramural fibroids and 
IMAEs have been implicated in heavy menstrual blood loss, and their ablation has been 
associated with reduction in bleeding over time [15]. Consequently, any technology that 
facilitates the targeting and treating of otherwise hard-to-reach fibroids is of benefit to 
the gynecologic surgeon as well as to the patient’s wellbeing.
Although this study lacks verification against a number of surgeons, it is the first and 
promising use in gynecology. A prospective multicenter and multi-user follow-up trial of 
the guidance system is planned.
Conclusion
The Acessa Guidance System displays the real-time relationship of the movements of the 
handpiece and laparoscopic ultrasound transducer in the pelvic cavity. It is the first and 
only computer-assisted image guidance system that has been FDA-cleared for commer-
cial use in laparoscopic surgery for uterine fibroid targeting and treatment. The positive 
user experience is evident in the facilitation of accurate handpiece tip placement during 
targeting and ablation of uterine fibroids.
Table 1 User (physician) preference testing: summary response statistics
TAG targeting animation guidance
a Statements were evaluated according to the following scoring system: (1) strongly disagree, (2) disagree, (3) neither 
disagree nor agree, (4) agree, (5), strongly agree
Subjects, N Mean scorea
Targeting statements
 The transducer and handpiece dynamic animation were helpful in targeting the 
fibroid
5 5 ± 0
 The use of TAG enabled the ability to reach the fibroid faster 5 5 ± 0
 Knowing the handpiece trajectory helped to target the fibroid 5 5 ± 0
 The transducer and handpiece dynamic animation helped visualize the positions 
of the actual transducer and handpiece in the cavity
5 5 ± 0
 The use of TAG provided confidence when targeting the fibroid 5 5 ± 0
Feature statements
 The center tip-to-plane meter was useful in staying in plane 4 4.75 ± 0.5
 The double green ring in the trajectory was useful in determining the location of 
the tip
5 3.6 ± 0.5
 The purple Targeting Zone was useful in determining where the tip intersected 
the ultrasound plane
5 5 ± 0
 While entering the fibroid and deploying the electrodes, it was easier to visualize 
the electrodes if the targeting zone was turned off
5 4.2 ± 0.8
 The messages below the two windows provided useful information 5 3.8 ± 0.4
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cMRI: contrast-enhanced magnetic resonance imaging; IMAE: intramural fibroid abutting the endometrium; LUS: laparo-
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